Centralization and Oncologic Outcomes in Ovarian Cancer

This is a multicenter, observational, retrospective and prospective study conducted within the REMO (Reggio Emilia - Modena) network in the Emilia-Romagna region (Italy), promoted by AUSL-IRCCS of Reggio Emilia. The study aims to evaluate the impact of surgical centralization and treatment strategies adopted during the COVID-19 pandemic on oncologic outcomes in patients diagnosed with the epithelial ovarian cancer (EOC) from 2018 to 2023. The retrospective component includes patients treated between 2018 and 2023, while the prospective component consists of clinical follow-up of those patients over the next five years.

NCT Number	NCT07075939
Lead Sponsor	Azienda USL Reggio Emilia - IRCCS Collaborators: AUSL di Modena - Ospedale Ramazzini di Carpi, AUSL di Modena - Ospedale di Mirandola, AUSL di Modena - Ospedale Civile di Sassuolo, AUSL di Modena - Ospedale di Pavullo nel Frignano, AUSL di Modena - Ospedale di Vignola, Azienda Ospedaliero-Universitaria di Modena
Conditions	Epithelial Ovarian Cancer, Ovarian Neoplasms, Advanced Ovarian Cancer
Enrollment	200 participants
Start Date	2025-06-27
Primary Completion	2030-06 (estimated)
Study Completion	2031-06 (estimated)
Updated on ClinicalTrials.gov	2026-07-24